13F Holdings
中文EN

NVST Envista Holdings Corp

Dental Equipment & Supplies · NYSE · SEC CIK 1757073 · Fiscal year ends 12/31

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY4,041.2%
TTM EPS YoY4,177.8%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR49.2%

Margins

Gross margin55.9%
Operating margin25.4%
Net margin22.0%
FCF margin8.4%
EBITDA margin29.3%

Returns

ROE20.5%
ROA11.3%
ROIC (approx.)20.0%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets45.0%
Debt / equity0.46x
Current ratio2.45x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.48x
Accruals ratio5.9%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.72B$2.51B$2.57B$2.57B$2.51B
Cost of revenue$1.23B$1.14B$1.13B$1.09B$1.08B
Gross profit$1.49B$1.37B$1.44B$1.47B$1.43B
R&D expense$114.00M$99.10M$93.80M$100.10M$100.50M
SG&A expense$1.16B$1.16B$1.06B$1.06B$1.02B
Operating income$216.10M-$1.04B$31.50M$319.20M$306.20M
Interest expense——$63.40M$38.40M$54.10M
Pretax income$177.20M-$1.08B-$54.90M$283.90M$254.50M
Income tax$130.20M$33.90M$45.30M$45.90M-$9.00M
Net income$47.00M-$1.12B-$100.20M$243.10M$340.50M
EBITDA$332.10M-$915.10M$167.10M$457.00M$424.00M
EPS (basic)0.28-6.50-0.601.492.11
EPS (diluted)0.28-6.50-0.601.371.92
Weighted avg. shares (diluted)169.20M172.20M166.90M177.60M177.60M
Balance sheet
Cash & equivalents$1.21B$1.07B$940.00M$606.90M$1.07B
Receivables$429.60M$363.00M$407.50M$393.50M$331.90M
Inventory$288.10M$241.00M$258.80M$300.80M$263.80M
Current assets$2.03B$1.79B$1.74B$1.42B$1.84B
PP&E, net$296.80M$277.00M$309.60M$293.60M$264.10M
Goodwill$2.36B$2.26B$3.29B$3.50B$3.13B
Intangibles$627.20M$649.90M$954.00M$1.09B$1.05B
Total assets$5.68B$5.35B$6.61B$6.59B$6.57B
Current liabilities$852.60M$878.70M$780.80M$1.24B$1.21B
Short-term debt$0$116.00M$115.30M$510.00M$432.40M
Long-term debt$1.45B$1.28B$1.40B$870.70M$883.40M
Total debt$1.45B$1.39B$1.51B$1.38B$1.32B
Total liabilities$2.57B$2.42B$2.43B$2.38B$2.52B
Shareholders' equity$3.11B$2.93B$4.17B$4.21B$4.06B
Net debt$236.60M$325.20M$573.40M$773.80M$242.20M
Shares outstanding163.80M172.20M171.50M163.20M161.60M
Cash flow statement
Operating cash flow$275.70M$336.50M$275.70M$182.70M$361.60M
Capital expenditure$45.30M$33.80M$58.20M$75.70M$54.70M
Free cash flow$230.40M$302.70M$217.50M$107.00M$306.90M
Investing cash flow-$51.10M-$54.60M-$62.40M-$657.30M$262.70M
Financing cash flow-$170.90M-$103.70M$118.90M$12.50M-$465.60M
Depreciation & amortization$116.00M$123.10M$135.60M$137.80M$117.80M
Stock-based compensation$37.60M$35.30M$30.70M$30.50M$28.20M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.